Alivus Life Sciences Q2 FY2027 Earnings Call Recording

• The document is an intimation regarding the availability of an audio recording for a Q2 FY2027 Earnings Call.
• The earnings call was held on October 30, 2026.
• The stated purpose of the event was to discuss the company's Q2 FY2027 results.
• The audio recording has been uploaded to the company's website at the following URL: https://alivus.b-cdn.net/alivuspdfs/investors/financials/reportspresentation/10048393.mp3.
• The disclosure is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30 and 46 read with Part A of Schedule III.
• The communication is addressed to the Manager – Listing at BSE Ltd. and the Department of Corporate Services at the National Stock Exchange of India Ltd.
• The signatory is Rudalf Corriea, identified as the Company Secretary & Compliance Officer.

Additional Notes Section

• This is a formal compliance letter and does not contain any financial highlights, guidance, or presentation summaries within its text.
• The document itself confirms the availability of the recording but does not disclose any unpublished price sensitive information (UPSI).
• No attachments (like presentation decks or transcripts) are mentioned as being included with this specific filing.